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Theclass I genes ofthe humanMHC influence many biologically important func-
tions associated with the immune response . These genesencode highly polymorphic
cell surface glycoproteins that represent the classical transplantation antigensHLA-
A, -B, and -C found on almost all nucleated cells. These cell surface antigens partici-
pate in the formation of the molecularcomplex recognized by the antigen receptor
ofCTL (1, 2) . As such, they are essential for the recognition and elimination of
virus-infected cells by the immune system . A complete class I molecule consists of
an u chain encoded by one of the closely linked polymorphic HLA-A, -B, -C genes
noncovalently bound to a a chain encoded by the unlinked nonpolymorphic a2 -
microglobulin gene. Polymorphism ofHLA class I antigens is believed to play an
important role in establishing the diversity ofimmune responsiveness within popu-
lations and constitutes the major barrier to tissue transplantation .
The murine homologues of the human class I transplantation antigens are en-
coded by genes in the H-2 region and include the classical H-2 K, D, and L an-
tigens . In addition to the genes encoding these antigens, the murine class I gene
family includes an additional 18-26 genes that map to the Qa and Tla regions . The
Qa- and Tla-encoded molecules are expressed on subpopulations oflymphoid cells
and some leukemias (3-5) . The differences in tissue distribution and the absence
of extensive polymorphism suggest that the function ofQa and Tla molecules may
differ from that of H-2 K, D, and L proteins .
In humans, there is considerable serological evidence for the existence of class
I-like antigens whose expression suggests they represent theequivalents ofthemouse
Qa and Tlaantigens (6, 7) . ExaminationofhumanDNAwith an HLA class I probe
indicated that the HLA-A, -B, and -C genes represent only a small subset of an ex-
tensive gene family (8) . Recent work cloning and characterizing all of the class I
homologous sequences from a human lymphoblastoid cell line (LCL)t has resulted
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in the identification of two class I-related genes (9-11) . These genes have been se-
quenced and shown to encode intact HLA class I proteins distinct from the classical
HLA-A, -B, and -C antigens. One gene, HLA-E, has been mapped between HLA-A
and HLA-C and shown to be expressed in a variety of tissues . The second gene,
designated HLA-6.0, encodes a class I-like molecule with a shortened cytoplasmic
region . This latter gene is expressed on the cell surface after transfer of the cloned
gene into human B-LCLs (12) .
We describe here the cloning and characterization ofa thirdhuman class I-related
gene, HLA-5.4 . The first six exons ofHLA-5.4 have an organization similar to that
ofHLA-A2, and the extracellular and transmembrane domains of the protein en-
coded by this gene are similar to those of the HLA-A, -B, and -C antigens . The
cytoplasmic segment of HLA-5.4 is predicted to be considerably shorter than that
of other HLA class I molecules . The 3' untranslated region ofHLA-5.4 is distinct
from that of all other class I genes . The first 32 by in this region are homologous
to other class I genes while the remainder of this sequence diverges completely.
Southern analysis indicated that thehuman genome contains 30-50 copies with ho-
mology to this unique 3' untranslated sequence, and Northern analysis showed that
at least some of these related sequences are transcribed in a variety of tissues . In
addition, we show that, unlike HLA-A, -B, and -C, the HLA-5.4 gene is differen-
tially expressed. Message from the HLA-5.4 gene can be detected in resting T cells,
skin cells, and in B-LCLs, but not in liver tissue or in the T cell line Molt-4 .
Materials and Methods
Cloning ofHLA-5.4 .
￿
Genomic DNA was obtained from LCL 721.144 and digested to com-
pletion with the restriction enzyme Hind III . Digested DNA was size selected on a prepara-
tive agarose gel, and the fractionated DNA was eluted into an agarose/hydroxyapatite gel
and purified as described (13). DNA from the fraction enriched for the 5.4-kb Hind III class
I sequence was ligated to Hind III-cut dephosphorylated X phage Charon 21a DNA, pack-
aged in vitro, and transfected into Escherichia coli LE 392 . Recombinants were screened by
hybridization (14) with an HLA-B7cDNA probe. 10 hybridizing plaques were picked, replated,
and screened a second time. DNA prepared from the plaque-purified clones was digested
with Hind III and analyzed by Southern blotting .
DNA Sequencing.
￿
A restriction map ofpHLA-5 .4 was constructed and appropriate frag-
ments were subcloned into M13-mp19 . For most of the sequence, sets of overlapping clones
were isolated by the deletion method of Dale et al . (15) . Where necessary, specific fragments
were subcloned into M13-mpl8 or M13-mp19 . Sequencing reactions were carried out by the
dideoxy-chain termination method (16) . The entire sequence presented in Fig . 2 was deter-
mined on both strands, and regions that remained ambiguous were resolved by using deox-
yinosine triphosphate as a substitute for deoxyguanosine triphosphate .
Analysis ofRNA andDNA.
￿
RNA was prepared according to the guanidium isothiocyanate
procedure described by Lizardi (17) . T lymphocytes were isolated from heparinized periph-
eral blood of normal healthy donors by Ficoll-Hypaque density gradiant centrifugation and
nylon wool filtration . Cells were cultured in 15o' PHA for 60 h before RNA isolation . Agarose
gels containing formaldehyde were used to separate the mRNA, and blotting onto a nylon
membrane and hybridization were carried out according to standard methods . GenomicDNA
was isolated and digested with restriction enzymes according to the supplier's specifications .
Digested DNA was separated on 0.770 agarose gels and transferred to a nylon membrane .
Hybridization conditions have been described (18). Washing for RNA and DNA blots was
in 0 .1 x SSC and 0.17o SDS at either 42'C or 68'C .
Preparation ofAntisenseRNA Probes andRNaseMapping.
￿
The 1,184-bp Bam HI-Pst I frag-
ment from the 5' coding region of HLA-5.4 (positions 1,393-2,577 in Fig. 2) was preparedGERAGHTY ET AL.
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and subcloned into the pSP64 vectoraccording to standardmethods. This subclone was charac-
terized and used as a source of antisense RNA probe. Hybridization of the labeled probe
(5 x 105 cpm) with 6 jig total RNA was performed overnight in 80% formamide at 45°C
(19). Protected fragments were analyzed on 6% acrylamide sequencinggels. PSP65 digested
by Nci I and end labeled with polynucleotide kinase was used as size marker.
Computer Analysis of DNA andProtein Sequence.
￿
The DNA and deduced protein sequence
of HLA-5.4 were analyzed with the Intelligenetics software on the SUN 3/160 computer of
the Molecular Biology Computer Facility, University of Minnesota. Sequence homology
searches were also performed on the Vax, University of Wisconsin.
Results
Isolation ofthe HLA-5.4 Gene.
￿
Southern blot analysis of LCL 721 genomic DNA
had previously indicated that a number of non-HLA-A, -B, and -C class I genes
were located within Hind III-generated fragments of 5.4 kb. Previous analysis of
cosmid clones isolated from an LCL 721 cosmid library led to the cloning of one
of these genes, HLA-5.4p. Subsequent examination of the HLA deletion mutant
cell line 721.144 (20) with a probe specific for HLA-5.4p indicated that both alleles
of HLA-5.4p were absent in this cell line. As 721 .144 still contained a 5.4-kb Hind
III fragment that hybridizes to a class I cDNA probe, this fragment must be con-
tributed by a second non-HLA-A, -B, or -C locus.
To clone this remaining 5.4-kb class I sequence, a partial genomic library was
constructed from size-selected Hind III-digested 721.144 DNA inserted in the A phage
vector charon 21a. Screening of the phage library with the HLA-B7 probe yielded
10 clones that all had identical restriction fragment patterns (data not shown). The
5 .4-kb Hind III fragment contained in one of these clones was subcloned into puc19
and designated HLA-5 .4. Fig. 1 shows a restriction map ofthe HLA-5.4 insert. With
overlapping clones obtained by exonuclease digestion (15) and subcloning ofrestric-
tion fragments, we determined 4,316 by of the nucleotide sequence beginning at
the 5' Pst I site and extending to the 3' Hind III site. Computer-assisted alignment
revealed strong sequence homology with the HLA-A2 gene and predicted the as-
signment of exon-intron boundaries in HLA-5.4.
General Structure ofthe HLA-5.4 Gene.
￿
The HLA-5.4 DNA sequence and the deduced
amino acid sequence are presented in Fig. 2. The overall structure of the HLA-5.4
gene is similar to other class I genes with sequence homology extending from the
5' flanking region into exon 8, the 3' untranslated sequence. There are, however,
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present in the DNA sequence
that is not cleaved by the en-
zyme (see Discussion). A schematic diagram of the region sequenced is shown below. Exons are in-
dicated by raised bars and labeled according to peptide domains. L, leader peptide; cel, a2, and 013,
the threeextracellular regions; Tm, transmembrane region; Cyto I and 2, the cytoplasmic regions. Control
sequences and a variant 3' splice site dinucleotide are indicated. Portions of HLA-5.4 used as probes
for Southern and Northern blots are indicated and designated 5.4E and 5.4H.4
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FIGURE 2 .
￿
The nucleotide and deducedamino acid sequence ofHLA-5.4 . Two polypurine tracts
in the 5' promoter region are underlined, as are the 5' and 3' splice site dinucleotides and the
polyadenylation signals . Potential enhancer and promoter sequences are boxed . Also boxed is
a variant 3' splice site dinucleotide at theendofintron 6 . A diamond lies over the point at which
the 3' untranslated sequence diverges from other HLA class I sequences . These sequence data
have been submitted to the EMBL/GenBank Data Libraries.
two unique features of the HLA-5.4 gene that affect the derived transcripts . The
predicted 5' and 3' splice sites alladhere to theGT andAG rules, with the exception
of the 3' splice site of intron 6, where AA replaces AG . Since the AG sequence is
conserved inmammaliangenes and point substitutions in this dinucleotide have been
shown to abolish splicing completely (21, 22), it is reasonable to conclude that exon
7 is spliced out of the mature HLA-5.4 transcript .GERAGHTY ET- AL .
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As is the case with HLA-A2, exon8 ofHLA-5.4 contains the last two nucleotides
of the codon for the COOH-terminal amino acid, the stop codon, and the 3' un-
translated region . After the stop codon, homology between HLA-5.4 and A2 con-
tinues foran additional 27 bp, after whichthe HLA-5.4 3' untranslated region diverges
completely from that of any other class I gene . This unique sequence does contain
twopolyAaddition signals (23) 90 basesdownstream from the stopcodon . Assuming
that exon 7 is spliced out and that the message is polyadenylated using these signals,
the HLA-5.4 mRNA is predicted to contain 1,250 nucleotides, including a 100-
nucleotide poly A tail . This compares with a size of 1,600 nucleotides found for a
similarly polyadenylated HLA-A, -B, or -C mRNA.
The unique portion of the HLA-5.4 3' untranslated region, from positions 3,799
to 4,316, was compared with other gene sequences compiled in theEMBOand Wis-
consin gene banks . With the exception of several GT repeats found 3' of the poly
A addition signals, no significant matches were found in either search.
Since this region was unique to HLA-5.4, a portion was subcloned for use as a
locus-specificprobe . Theprobe p54E extendsfrom theEcoRV site at position 3,828
to the Taq I site at position 4,109 . Fig . 3 shows Southern blot analysis ofDNA from
LCL 721 and from derived related cell lines . Underlow stringency conditions (42°C),
at least30 distinct bandswere seen . This suggested that the HLA-5.4 3' untranslated
region contains a sequence homologous to a second distinct multigene family. This
gene family did not appear to have been previously characterized since no homolo-
gies with published sequences could be found . Under high stringency conditions
FIGURE 3 .
￿
Southern analysis ofDNAfromLCL
721 and derived cell lines . 10 jig ofLCL721 and
mutant cell lineDNAwas digested with Hind III,
separated on a0.77o agarose gel, transferred to
anylonmembrane, and hybridized with the sub-
clone 5.4E . Mutant cell line .77 .1 hasa deletion
ofthe shortarmofchromosome 6 containing the
A2:Glo1 haplotype ; mutant .45.1 hasa deletion
of the short armofchromosome 6 containing the
Al:Glo2 haplotype; and .144 has a homozygous
deletion ofDNA at the HLA-A locus (20) . The
membrane was washed at 42°C in A and 68°C
in B.6
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(68°C), p54E hybridizes to a single band at 5.4 kb, demonstrating that this probe
is specific to the HLA-5.4 gene, and that the HLA-5.4 cloned sequence is represen-
tative of that found in the human genome.
ComparisonsoftheDNAandProtein SequenceofHLA-5. 4.
￿
Comparisons of HLA-5.4
with five nonallelic class I genes are presented in Table I. As wasfoundwith HLA-E,
the evolutionary position of HLA-5.4 is somewhat ambiguous. With the exception
of intron 3ofHLA-E, HLA-5.4 has similarhomology with anyoftheseclassI genes
from the 5' flanking region through exon 5. The 3' portion of HLA-5.4 shows more
homology to the HLA-A2 and -6.0 genes than to HLA-Bw58, -Cw3, or -E. Compar-
ison of the sequences from intron 6 through intron 7 allows these six genes to be
placed in two groups. The HLA-5.4, -A2, and -6.0 sequences share 86-90% ho-
mology among themselves, while sharing 71-79% homology with the HLA-Bw58,
-Cw3, and -E sequences. Similarly, HLA-Bw58, -Cw3, and -E have 86-90% ho-
mology in this region.
The pattern of divergence of the HLA-5.4 protein sequence from other class I
proteins is similar to that seen when comparing the HLA-A, -B, and -C genes (see
Table I). The HLA-5.4 protein is highly conserved in the 0 domain presumably
due to the importance of this region in the interaction with N2-microglobulin. The
al and a2 domains show 62-76% homology with the corresponding domains of
other HLA class I molecules. Similar to comparisons between HLA-A, -13, and -C
proteins, the HLA-5.4 al and a2 domains are nearly equally diverged from those
of HLA-A2, -Bw58, -Cw3, and -6.0 proteins. This is in contrast to HLA-E, which
shows significantly more divergence in a2 than in al.
Previous studies comparing class I protein sequences have identified hypervari-
able regions within the a1 and a2 domains (24). Most of the variable residues are
clustered in regions from positions 57 to 83 in al and from positions 143 to 171
TABLE I
Percentage of DNA and Protein Sequence Identity between HLA-5.4 and Homologous Class I Genes
Gene segment
5.4/A2
DNA Protein
5.4/Bw58
DNA Protein
5.4/Cw3
DNA Protein
5.4/6.0
DNA Protein
5 .4/E
DNA Protein
5' Promoter 80 81 79 80 75
Exon 1 85 86 88 72 90 86 92 81 78 71
Intron 1 86 88 86 89 86
Exon 2 82 71 81 73 83 71 84 76 80 69
Intron 2 81 84 83 82 82
Exon 3 81 71 84 76 84 76 82 73 78 62
Intron 3 84 85 84 86 70
Exon 4 89 88 91 92 92 90 91 89 92 90
Intron 4 83 90 85 80 90
Exon 5 93 82 87 74 88 72 91 82 91 77
Intron 5 86 82 80 88 88
Exon 6 91 82 88 64 79 55 88 - 76 45
Intron 6 87 82 72 89 81
Exon 7 87 - 83 - 75 - 79 - 79 -
Intron 7 84 68 69 86 73
3' untranslated 92 76 79 - -ina2 . Likewise, the substitutionsfound in the HLA-5.4 protein are clustered within
these regions (see Fig . 4) .
Both of the cysteine pairs found in a2 and a3 and conserved among all MHC
class I antigens are present in identical positions in the HLA-5.4 protein . A single
N-linked glycosylation site, Asn-86, is found in the al region . The transmembrane
segment ofHLA-5.4 is identical in length and very similar in amino acid sequence
to that of the HLA-A, -B, and -C proteins . The predicted cytoplasmic segment of
HLA-5.4 would be 16 amino acids shorter than that of other HLA molecules if,
as discussed above, exon 7 is spliced out of the mature HLA-5.4 transcript . The
molecular mass of the HLA-5.4 protein should therefore be 2,000 daltons less than
that of the classical HLA proteins . We have introduced the HLA-5.4 gene into B
lymphoblastoid cells as part of an extrachromosomal plasmid (12) . Expression of
the HLA-5.4 protein in these cellscouldbe demonstrated withmAbw6/32, a mono-
morphic class I antibody, andmAb BBM.1, which binds free or a chain-associated
R2-microglobulin . As predicted, the HLA-5.4 protein has an apparent molecular
mass of 41,000 daltons, -2,000 daltons less than that of the HLA-A, -B, and -C H
chains .
While the general pattern of substitutions found in the HLA-5.4 protein is typ-
ical, an examination of the conserved residues of class I proteins shows HLA-5.4
to be significantly different . The recently determined three-dimensional structure
ofHLA-A2 and thedelineation of the antigen binding site of class I antigens afford
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FIGURE 4 .
￿
Comparison of the al, a2, and a3 domains of class IHLA proteins . The amino
acid sequence ofthe al-a3 domains oftheHLA-5.4 protein is shown using the single letteramino
acid code . Aligned underneath are correspondingsequencesfrom HLA-6.0 (9), HLA-E (11), HLA-
A2 (13), HLA-Bw58 (42), andHLA-Cw3 (43). Dashes denote identity to the respective position
in theHLA5.4 sequence. Amino acids boxedand underlined mark positionsin the antigen binding
site conserved among class I proteins (see Discussion) .8
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an opportunity to examine the corresponding functional sites of the HLA-5.4 pro-
tein (25, 26) . There are 10 completely conserved residues (including five tyrosines)
pointing into the antigen recognition site in 22 human sequences . These residues
in the HLA-5.4 protein are shown in Fig. 4. 5 ofthe 10 conserved residues are different
in HLA-5.4 . The significant changesincludesubstitution ofa tyrfor phe at position
22, a glu for gly at position 26, and an arg for tyr at position 84 . Four of the five
conserved residues are tyrosines, and a fifth tyr residue is introduced at position
22 . In contrast, 8 of the 10 residues are conserved in HLA-E, and 9 of the 10 are
conserved in HLA-6.0, in both cases including all five tyrosines. In the murine Tla
gene 37.1, 8 of the 10 residues are conserved, again including all five tyrosines (27) .
All ofthe substitutions at these positions in the latter threeproteins areconservative .
The conserved residues in thelong helix of the al domain are conserved in HLA-
5.4, the only exception beingan asp to glu substitution at position 61 . Thelong helix
ofa2 shows more variability, including a lys to phe substitution at position 146 and
an ala to glu substitution at position 150 . The0 helix in HLA-E shows approxi-
mately the same extent of divergence, with gly to asp substitution at position 162
and an arg to his at position 169 .
Identification of Potential Promoter Sequences in the HLA-5.4 Gene.
￿
In the 5' untrans-
lated region of class I genes, there are at least five promotor sequences thought to
be important in regulating transcription . Sequences of class I promoter regions are
shown aligned in Fig . 5, including the published sequences ofHLA-A2 (13), HLA-E
(11), and HLA-6.0 (9) . The 5'850 by of HLA-5.4 are aligned with these other class
I sequences, highlighting potential control sequences . The homology extends over
the entire length of available sequence for any combination of the HLA-A2, HLA-
6.0, andHLA-5.4 genes . TheHLA-E gene shares homology for 190 by 5' from the
ATG start to homology A (see Fig . 5), at which point this sequence diverges com-
pletelyfrom the others . The HLA-5.4 promoter has theCAAT and variant TCTAA
homology found in most otherHLA class I genes (an exception being HLA-E, which
has the more typical TATAA homology) .
Two potential regulatory sequences have been identified in murine class I genes
(28) and have also been found in HLA class I genes (Fig . 5, A and B) . Homology
A is a 13-bp palindrome that has been shown to be the binding site for a protein
factor that interacts with the H-2K promoter (29, 30), andavariant of thishomology
is also found in the murine 02-microglobulin promoter (30) . Both the sequences
from the H-2K and the R2-microglobulin promoters show enhancer and protein
binding activities, while a sequence from theQ10 promoter, having two base substi-
tutions relative to the H-2K homology, shows neither activity . HomologyA inHLA-5.4
is altered at two positions, one of which, a G to A substitution at position three,
is identical to that found in the Q10 sequence (28) . As previously noted, the HLA-
6.0 gene shows a deletion of part of this sequence, and the HLA-E gene has no se-
quence resembling this homology in its 5' region . Homology B is an 11-bp sequence
found in allthe published HLA-A, -B, and -C sequences, andafragment containing
a nearly identical sequence from the murine H2-K, -D, and L promoters has been
shown to have enhancer activity (28) . TheHLA-5.4 promoter has asingle base variant
ofthis sequence . The substitution found in theHLA 5.4 homology B is distinct from
either of the two substitutions found in the HLA-6.0 sequence and distinct from
the single substitution found in the HLA-E homology.GERAGHTY ET AL.
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The IFN consensus sequence (ICS)represents the fifth putative promoter sequence
found in the HLA class I genes (31, 32) . An ICS very similar to the human ICS
has also been found in amurine H-2L gene (33) . As canbe seen in Fig . 5, the HLA-
6.0 gene has most of the ICS deleted and has no closely homologous sequence any-
where in the promoter region . TheHLA-E 5' region contains a sequence with good
homology to the ICS . The HLA-5 .4 ICS is very close to the consensus and, in fact,
is no more diverged than is the HLA-A2 ICS .
Examination of the HLA-5.4 promoter further upstream identifies two stretches
of sequence similar to regulatory elements found near other mammalian genes (se-
quences 1 and 2, Fig. 5) . Sequence 2 in HLA-5.4 consists of 25 purines with three
tandem GGGGGA repeats . Sequence alignment shows that HLA-A2 and HLA-6.0
are also purine rich in this region, while HLA-E is not. The HLA-A2 and -6.0 se-
quencesare nearly identical to each otherbut are shorter, differ in base composition,
and lack the repeat structure of the HLA-5 .4 sequence. Themost striking sequence
to be found in the HLA-5.4 5' region is an uninterrupted stretch of 184 purine residues
extending from positions 110 to 293 (Fig. 2). This region contains 47 occurrences
ofthetrinucleotideGAA and 15 ofGAG, includingGAA tandemly repeated 21 times.
Murine class I genes also contain a similar purine-rich stretch. The H-2Kk gene
has a 45-bp region consisting of 42 purines with five GAAGA repeats ending 330
by upstream of the ATG start (28) . A closely homologous stretch of purines also
occurs at the same position in the murine Qa region genes, Q10 and 27 .1 .
The HLA-6.0 gene does not contain a similar stretch of sequence . Despite close
homology to HLA-5.4 on both the 5' and 3' sides of sequence 1, the corresponding
HLA-6.0 sequence is much shorter (20 bp) and, while containing 15 consecutive
purines, lacksany similar trinucleotide repeats . The HLA-Cwl and -Cw2 genes both
have a stretch of 10 purines, also without the trinucleotide repeat structure, in an
analogous position (34) . There is less homology between the surroundingsequences
of these genes and those ofHLA-5 .4, however, making the alignment somewhat ar-
bitrary .
Expression of the HLA-5.4 Gene and Related Transcripts .
￿
Northern analysis was car-
ried out on a variety of human tissues and cell lines in order to determine which
tissues express the HLA-5.4 gene and to examine whether any of the HLA-5.4 3'
untranslated (ut) related sequences are expressed . Subclone p54E was used as the
source of probe, since Southern blot analysis indicated that this sequence should
hybridize with members ofthe HLA-5.4 3' related multigene family underlow strin-
gency conditions and specifically with HLA-5.4 under high stringency conditions .
Ascan be seen in Fig. 6, the p54E probe hybridized with several distinct RNA spe-
cies, some of which appear to be cell and tissue specific . One species, which ap-
peared to be the most abundant message, was found in all tissues and cell lines ex-
amined . The relative size of this RNA was 600 nucleotides and, as seen in Fig . 6,
it was polyadenylated .
Thepresence ofthe600-nucleotide message in all tissues suggested that thismRNA
might perform ahousekeeping function and, therefore, that a similar RNA might
be present in othermammaliantissue. To address this question, Northern and Southern
analysis o£ mouseRNA and DNA was performed (Fig . 7) . The HLA-5.4 ut mul-
tigene family probehybridized to mouseDNA, andthe complexity of thehybridiza-
tion pattern suggested that these sequences compriseasimilarly sized multigene family.GERAGHTY ET AL .
￿
11
FIGURE 6.
￿
Northern analysis ofRNA
from various cell lines and tissues.
RNAwas fractionated on a1% agarose
gel containing 2.2 M formaldehyde,
transferred to a nylonmembrane,and
hybridized with the 5.4E probe . pA,
polyadenylated mRNA fraction ; FT,
flow-through nonpolyadenylated frac-
tion ; and T, total RNA. Washing was
at 42°C. See Materials and Methods
for details .
The Northern analysis showed that at least one of these mouse sequences is tran-
scribed as an mRNA with size similar to the ubiquitous human message . Other
mouse tissues and cell lines have been examined, and all showed a 600-nucleotide
RNA species that hybridized to the p54E probe (data not shown) .
In addition to the 600-nucleotide mRNA, there were at least four additional dis-
tinct RNA species that hybridized with p54E in LCL 721, Molt-4, and spleen cells .
Not all of these RNA species were expressed in all cell types . For example, Molt-4
had a 2,$00-nucleotide species not present in the other cell types, and RNA from
spleen contained a 1,400-nucleotide species unique to this tissue. In addition, the
relative amountsofRNAspecies common to these cells appeared to vary in different
cell and tissue types . This could reflect differences in the level of expression of a
given member of themultigene family. Alternatively, any single band may be com-
prised ofmore than oneRNA species, some ofwhich may be expressed in a tissue-
specific manner.
To examine theexpression ofHLA-5.4, the Northern blots were subjected to the
same high stringency washing used for the Southern analysis. However, it was not
possible to unambiguously demonstrate expression ofHLA-5.4 using this approach .12
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FIGURE 7 . Northern and Southern
analysis ofhuman and mouse tissues .
(A)Human DNA from LCL-721 and
mouse DNA from cell line EL4 was
digested to completion with the indi-
catedenzymes (B, Barn HI ; E, EcoRI ;
H, Hind III ; S, Sst I) . These DNAs
were separated on an agarose gel, trans-
ferred to nylon membranes, and probed
with the5.4E probe. (B)HumanRNA
andmouse spleen RNA was fraction-
ated on an agarose gel and subjected
to Northern analysis with the 5.4E
probe.
RNA was therefore analyzed usingan RNase protection assay . The source of probe
used in this analysis was a 1,184-bp Bam HI-Pst I fragment from the 5' coding re-
gion (positions 1,393-2,577) subcloned into the vector pSP64. This fragment con-
tains all of exon 3, the HLA-5.4 coding sequence most diverged from other class
I sequences . Of the full-length SP6-transcribed RNA, 274 bases protecting exon
3 ofHLA-5 .4mRNA should be left undigested afterRNase treatment. Fig . 8 shows
protected fragments of the expected size could be found when hybridized toRNA
from a variety oftissues and cell lines . T cells appear to have levels comparable with
that found in B-LCLs and slightly higher levels than that found inPHA blasts . HLA-
5 .4 mRNA could also be detected in skin but not in RNA derived from liver. In
addition, mRNA from B-LCLs derived from five unrelated individuals also pro-
tected a fragment of the same size (data not shown), implying that this portion of
HLA-5 .4 mRNA is not extensively polymorphic in the population . No protected
fragment was seen when Molt-4RNA was used, even after exposures 20-fold longer
than that shown in Fig. 8 . This analysis establishes that the HLA-5.4 gene is tran-
scribed in human cells and indicates that this expression is tissue or cell type specific .
Discussion
HLA-5 .4 is the third non-HLA-A,B,C gene isolated from LCL 721 . TheHLA-5.4
gene is unique in being composed of anHLA class I sequence linked to a sequence
that is a member ofa distinct multigene family comprising part of the 3' untrans-
lated region . Thesequence indicates that HLA-5.4 encodes an intact class I protein,
and we have shown here that HLA-5 .4mRNA is present in B-LCLs and in resting
T cells . Whereas HLA-E mRNA was found expressed at low levels in all cells and
tissues examined, this was not the case with HLA-5 .4, since no mRNA was found
in the leukemic T cell line Molt-4 .
Since the HLA-5.4 gene has a pattern of expression distinct from the five other
class I genes, it might be expected that the HLA-5 .4 promoterwouldcontain uniqueGERAGHTY ET AL .
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FIGURE 8 .
￿
Expression of HLA-5.4 mRNA in
different cell lines . The pSP64 probe and the
RNase mapping assay used are described in
Materials and Methods .The origin oftheRNA
is indicated above each lane. The undigested
probe is included forcomparison .The size marker
is pSP65 cut with Nci I and end labeled.
regulatory elements . Studies of class I promoter sequences in the mouse have led
to the identification and purification of a factor with binding activity specific for
H-2 and (32-microglobulin enhancer sequences (30) . The 13-bp palindromic se-
quence in the H-2K gene, to which this factor binds, is found unchanged in the
HLA-A and -B genes . It is interesting to note that this sequence is found altered
in the HLA-5.4 promoter and partially or completely absent in the HLA-6.0 and
HLA-E promoters . The HLA-5.4 andHLA-6.0 genes are differentially expressed,
and HLA-E is constitutively expressed at a much lower level than the HLA-A and
-B genes. TheHLA-C gene also contains an a..ered versionofsequence A with two
substitutions, both of which disrupt the palindromic nature of the sequence . HLA-
C is expressed at N2% the level of HLA-A and -B . It seems reasonable to suggest,
then, that sequence A as found in the H-2K promoter and in HLA-A2 is necessary
for the high level constitutive expression of HLA-A and -B genes.
Expression of the HLA-5.4 gene may be modified not only by the alteration of
existing regulator motifs, but also by the presence of sequences not found in other
class I genes . Thus, the shortpolypurine stretch found 300 by upstream of theATG
codon (sequence 2 in Fig . 5)may have regulatory activity. Several studieshave shown
that S1 hypersensitive sites are frequently located within short polypurine/polypyrimi-
dine tracts, and nuclear protein factors have been identified that bind at or near
these sites (35) . Some of these stretches, located in 5' flanking regions, canmodulate
localDNA structure when subjected to superhelical stress, thereby altering the con-
formation of neighboring sequences (36) .
Thesecond longer polypurine stretch (sequence 1 in Fig. 5) may also exert aunique
regulatory influence on the HLA-5.4 gene.A similar size sequence with a different14
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repeat structure has been described in a chicken myosin H chain gene (37) . The
long polypurine stretch in the chicken myosin H chain gene appears to induce a
continuous long range helical distortion of the flanking DNA. In this regard it is
interesting to point out that the Xba I site found 5 by 3' of the end of sequence
1 in HLA-5.4 is not cleaved by this enzyme . Since this site does not overlap with
a dam methylation site, and is therefore presumably not methylated, we speculate
that the helical distortion induced by sequence 1 may interfere with Xba I recogni-
tion or activity.
An additional aspect of sequence 1 concerns the means by which this sequence
evolved . Since the HLA-5.4 and HLA-6.0 genes have arisen from a common an-
cestor, the manner in which these genes diverged points to different evolutionary
mechanisms . The regions flanking sequence 1 appear to have diverged throughrandom
base substitutions . The polypurine stretch, on the other hand, must have evolved
byDNA slippage andmispairing during replicationand recombination . The HLA-
6.0 sequence may have lost a part or all of a precursor sequence, while the HLA-5 .4
sequencemay haveadded sequence to theprecursor. It hasbeen suggested that ubiq-
uitous slippage-like mechanisms are a major source of genetic variation, not pre-
dictable by the classical mutation process (38) . Perhaps these genes represent ex-
amples of such mechanisms .
The predicted protein structure of HLA-5.4 suggests a biological role different
from that ofother class I proteins . Examinationof theconserved residues has shown
the HLA-5.4 protein is unique among all class I proteins, including examples from
the murine Tla region . Only 5 of the 10 highly conserved residues pointing into
the antigen binding site remain unaltered in HLA-5.4 (see Fig . 4) . At least three
of these substitutions are not conservative, implying that the function imparted on
class I proteins by these residues has been lost or altered in HLA-5 .4 . Perhaps the
HLA-5.4 protein is able to bind antigenbut is restricted byaunique subset ofTCRs.
This possibility is intriguing considering the uncertainty ofthe ligand oftheTCR,y/&
A second question about the function of the HLA-5.4 protein relates to the pat-
tern of cell surface expression . We have shown that HLA-5.4 mRNA is present in
B-LCLs and that HLA-5.4 protein can be detected in the cytoplasm but not on the
surface of these cells (12) . One explanation is that HLA-5.4, like several murine Qa
proteins, is secreted . This possibility seems unlikely because the transmembrane
segment oftheHLA-5.4 protein differs from theHLAA2 protein at only four residues,
and none of these changes would be expected to alter the hydrophobicity . The mu-
rine Q6 and Q7 proteins, both ofwhich are secreted, also have a high degree of
hydrophobicity in theTM regions, although both do contain single charged amino
acid in the center ofthis segment (39) . It is also possible that the shorter cytoplasmic
segmentpredicted forHLA-5.4 might effect itsmembrane anchoring . However, studies
ofmurine class I antigens with truncated cytoplasmic domainshave shown that these
altered proteins are expressed on the cell surface (40) . In addition, HLA-6.0, which
has acytoplasmic segment of six amino acids, can be found on the cell surface (12) .
It is possible, however, that theHLA-5.4 protein is processed in someunknown manner
resulting in its secretion . For the variable surface glycoprotein, which is known to
be attached to cell membranes through aphospholipid tail, it has been demonstrated
that the hydrophobic transmembrane region predicted from the cDNA sequence
is absent from the mature protein (41) .GERAGHTY ET AL .
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One remarkable aspect of the HLA-5.4 gene is the sequence found in the 3' un-
translated and flanking DNAs . Whether or not the presence of this sequence con-
tributes to the unique expression pattern of HLA-5.4 is not known . The sequence
is, however, a member of a multigene family consisting of at least 30 members. A
number of these aretranscribed either independently or as a result oftheir insertion
into other expressed genes. The most abundantly transcribed sequence, a 600-
nucleotide polyadenylated RNA, was found in all human cells and tissues exam-
ined . A similar number of related sequences were identified in the mouse genome,
and at least one of these is transcribed, also yielding a 600-nucleotidemRNA . The
function of this RNA is unknown but a comparison of the human and mouse se-
quences might be revealing. We have isolated cDNA clones derivedfrom both mouse
andhuman tissues (D. E. Geraghty andB. H . Koller, unpublished results) and are
currently performing this analysis .
Several related transcripts distinct from the 600-nucleotidemRNA are also found
in a variety of tissues, and some of these transcripts appear to be differentially ex-
pressed . It maybe interesting to note that some ofthese transcripts have been found
only inlymphoid tissues and derived cell lines. We have not yetdetermined whether
the sequence shared by these transcripts is contained in the 3' untranslated region,
as found in HLA-5.4, nor how much sequence is shared among them. Answers to
these questions may reveal information about the unique function, if any, this se-
quence has as part of the HLA-5.4 mRNA.
The HLA-5.4 gene appears to represent a recombinant between members oftwo
multigene families very diverse in sequence but with some general features in common .
Both families areof similar size with theHLA class I family, containing 17 members
compared with 30 sequences homologous to the p54E sequence . In addition, both
have members that are transcribed constitutively at relatively high levels (the 600-
nucleotide mRNA and HLA-Aand -B), andmembers that are differentially expressed
(the Molt-4 and spleen-specificmRNAs, HLA-6.0 and-E, and HLA-5.4, a member
of both groups) .
Summary
We describe here the isolation and sequencing of a previously uncharacterized
HLAclass I gene . This gene, HLA-5.4, is the thirdnon-HLA-A,B,C gene character-
ized whose sequence shows it encodes an intact class I protein . RNase protection
assays with a probe specific for this gene demonstrated its expression in B lympho-
blastoid cell lines, in restingT cells, and skin cells, while no mRNA could be de-
tected in theT cell line Molt 4. Consistent with a pattern of expression different
from that of other class I genes, DNA sequence comparisons identified potential
regulator motifs unique to HLA-5 .4and possibly essential for tissue-specific expres-
sion . Protein sequence analysis ofhuman and murine class I antigens has identified
10 highly conserved residues believed to be involved in antigenbinding . Five ofthese
arealtered inHLA-5.4, andofthese, threearenonconservative . In addition, exami-
nation of the HLA-5 .4DNA sequence predicts that the cytoplasmic segment ofthis
protein is shorter than that of the classical transplantation antigens . The 3' untrans-
lated region of the HLA-5.4 gene contains one member of a previously undescribed
multigene family consisting of at least 30 members . Northern analysis showed that
several of these sequences were transcribed, and the most ubiquitous transcript, a1 6
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600- nucleotide polyadenylatedmRNA, was found in all tissues and cells examined .
This sequence is conserved in themouse genome, where a similarnumber of copies
were found, and one of these sequences was also transcribed, yielding a 600-nucleo-
tidemRNA . The characterization of this uniqueHLA class I gene and the demon-
stration of its tissue-specific expression have prompted us to propose that HLA-5.4
be designated HLA-F.
Receivedfor publication 27 April 1989 and in revisedform 29 August 1989.
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